Shawn M. Jensen

Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40

David J. Messenheimer, Shawn M. Jensen, Michael Afentoulis et al. · Clinical Cancer Research · 2017 · 310 citations · Full text

Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells

Petra Schuberth, Christian Hagedorn, Shawn M. Jensen et al. · Journal of Translational Medicine · 2013 · 204 citations · Full text

Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC

Robert Saddawi‐Konefka, Aoife O’Farrell, Farhoud Faraji et al. · Nature Communications · 2022 · 152 citations · Full text

Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10

Cristina Bergamaschi, Hrishikesh Pandit, Bethany A. Nagy et al. · Journal for ImmunoTherapy of Cancer · 2020 · 141 citations · Full text

Tumor‐specific <scp>CD</scp>4⁺<scp>T</scp> cells maintain effector and memory tumor‐specific <scp>CD</scp>8⁺<scp>T</scp> cells

S. Church, Shawn M. Jensen, Paul A. Antony et al. · European Journal of Immunology · 2013 · 105 citations · Full text

T-regulatory Cell, Immunology, Immunoediting +22